HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $9,000 | -30.8% | 40,001 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | -18.8% | 40,001 | 0.0% | 0.00% | – |
Q1 2018 | $16,000 | +14.3% | 40,001 | 0.0% | 0.00% | – |
Q4 2017 | $14,000 | +7.7% | 40,001 | 0.0% | 0.00% | – |
Q3 2017 | $13,000 | -35.0% | 40,001 | 0.0% | 0.00% | – |
Q2 2017 | $20,000 | -9.1% | 40,001 | -0.0% | 0.00% | – |
Q1 2017 | $22,000 | – | 40,006 | +800020.0% | 0.00% | – |
Q4 2016 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,938,374 | $620,000 | 0.10% |
Occidental Asset Management, LLC | 15,834 | $5,000 | 0.00% |
Waldron Private Wealth LLC | 11,000 | $3,000 | 0.00% |
VANGUARD GROUP INC | 467,574 | $150,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
UBS Group AG | 20,658 | $7,000 | 0.00% |
Advisor Group, Inc. | 250 | $0 | 0.00% |
Jacobi Capital Management LLC | 318 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 2,501 | $0 | 0.00% |
CITY HOLDING CO | 417 | $0 | 0.00% |